South Korea Allocates over $450 Billion For Biotech in 2021
Published December 22nd, 2020 - 12:00 GMT
The ministry said it will spend 31.7 billion won on COVID-19 treatment and vaccine development next year and 10.2 billion won to acquire technology to respond to new infectious diseases, Yonhap New Agency reported. (Shutterstock)
Highlights
The Ministry of Science and ICT said the figure represents a 24.9 percent hike from 2020.
South Korea said Tuesday it will invest 520 billion won ($470 billion) in biotechnology next year as part of efforts to develop treatment and vaccines for COVID-19.
The Ministry of Science and ICT said the figure represents a 24.9 percent hike from 2020.